Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies
Risperidone (RSP) is an atypical antipsychotic drug which acts as a potent antagonist of serotonin-2 (5TH2) and dopamine-2 (D2) receptors in the brain; it is used to treat schizophrenia, behavioral and psychological symptoms of dementia and irritability associated with autism. It is a poorly water s...
Main Authors: | Laura Sbârcea, Ionuț-Mihai Tănase, Adriana Ledeți, Denisa Cîrcioban, Gabriela Vlase, Paul Barvinschi, Marinela Miclău, Renata-Maria Văruţ, Cristina Trandafirescu, Ionuț Ledeți |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/23/5694 |
Similar Items
-
Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients
by: Laura Sbârcea, et al.
Published: (2021-03-01) -
Physicochemical characterization of zofenopril inclusion complex with hydroxypropyl-β-cyclodextrin
by: Udrescu Lucreţia, et al.
Published: (2015-01-01) -
Enhancement of iodinin solubility by encapsulation into cyclodextrin nanoparticles
by: Anthony Prandina, et al.
Published: (2018-01-01) -
Improvement of the Solubility and Dissolution Characteristics of Risperidone via Nanosuspension Formulations
by: Hayder Emad, et al.
Published: (2022-06-01) -
Preparation, characterization, and biological activity of the inclusion complex of dihydroquercetin and β-Cyclodextrin
by: Yaping Xu, et al.
Published: (2023-10-01)